P4 medicine: how systems medicine will transform the healthcare sector and society.

Ten years ago, the proposition that healthcare is evolving from reactive disease care to care that is predictive, preventive, personalized and participatory was regarded as highly speculative. Today, the core elements of that vision are widely accepted and have been articulated in a series of recent reports by the US Institute of Medicine. Systems approaches to biology and medicine are now beginning to provide patients, consumers and physicians with personalized information about each individual's unique health experience of both health and disease at the molecular, cellular and organ levels. This information will make disease care radically more cost effective by personalizing care to each person's unique biology and by treating the causes rather than the symptoms of disease. It will also provide the basis for concrete action by consumers to improve their health as they observe the impact of lifestyle decisions. Working together in digitally powered familial and affinity networks, consumers will be able to reduce the incidence of the complex chronic diseases that currently account for 75% of disease-care costs in the USA.

[1]  Joseph P Shivers,et al.  Continuous glucose monitors: current status and future developments , 2013, Current opinion in endocrinology, diabetes, and obesity.

[2]  Leroy Hood,et al.  Systems biology, proteomics, and the future of health care: toward predictive, preventative, and personalized medicine. , 2004, Journal of proteome research.

[3]  H. Stefánsson,et al.  Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes , 2006, Nature Genetics.

[4]  Jacob Köhler,et al.  Addressing the problems with life-science databases for traditional uses and systems biology , 2006, Nature Reviews Genetics.

[5]  D. Galas,et al.  Diseases as network perturbations. , 2010, Current opinion in biotechnology.

[6]  A. Schneeweiss,et al.  Personalized Therapy in Breast Cancer , 2012, Oncology Research and Treatment.

[7]  D. Umberson,et al.  Social Relationships and Health: A Flashpoint for Health Policy , 2010, Journal of health and social behavior.

[8]  D. Katz,et al.  PREVENTIVE MEDICINE, INTEGRATIVE MEDICINE & THE HEALTH OF THE PUBLIC , 2009 .

[9]  J. Wardle,et al.  Psychological Responses to Genetic Testing for Weight Gain: A Vignette Study , 2012, Obesity.

[10]  Amar Patel,et al.  Current and future role of biomarkers in Crohn’s disease risk assessment and treatment , 2011, Clinical and experimental gastroenterology.

[11]  Sean P Mullen,et al.  Increasing Physical Activity With Mobile Devices: A Meta-Analysis , 2012, Journal of medical Internet research.

[12]  Jaeyun Sung,et al.  Molecular signatures from omics data: From chaos to consensus , 2012, Biotechnology journal.

[13]  Inyoul Y. Lee,et al.  A systems approach to prion disease , 2009, Molecular systems biology.

[14]  G. Omenn A landmark systems analysis of prion disease of the brain , 2009, Molecular Systems Biology.

[15]  G. Nolan,et al.  Computational solutions to large-scale data management and analysis , 2010, Nature Reviews Genetics.

[16]  J. Wright,et al.  Genetics: Prostate cancer risk stratification by genotype and PSA , 2009, Nature Reviews Urology.

[17]  Charles M Perou,et al.  Molecular stratification of triple-negative breast cancers. , 2010, The oncologist.

[18]  E. Juengst,et al.  After the revolution? Ethical and social challenges in 'personalized genomic medicine' , 2012, Personalized medicine.

[19]  Michael E Phelps,et al.  Systems Biology and New Technologies Enable Predictive and Preventative Medicine , 2004, Science.

[20]  Rudi Balling,et al.  Revolutionizing medicine in the 21st century through systems approaches. , 2012, Biotechnology journal.